Home
About us
Solutions
THIN
Contact
UK
Endocrinology
Accueil
Publications
Endocrinology
Postauthorization safety study of the DPP-4...
Postauthorization safety study of the DPP-4 inhibitor saxagliptin: a large-scale multinational family of cohort studies of five outcomes.
Des questions sur notre activité ?
Contactez-nous